How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?

Br J Haematol. 2020 Apr;189(2):239-240. doi: 10.1111/bjh.16597. Epub 2020 Mar 16.
No abstract available

MeSH terms

  • Betacoronavirus*
  • Blood Donors
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / prevention & control
  • Coronavirus Infections* / transmission
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Immunocompromised Host
  • Pandemics* / prevention & control
  • Pneumonia, Viral* / prevention & control
  • Pneumonia, Viral* / transmission
  • SARS-CoV-2